- Life Sciences
- Conference
Liquid Biopsy for Precision Oncology Summit 2025
Tempus is advancing precision medicine through the practical application of artificial intelligence in healthcare. We are pleased to share more information about our novel approach to liquid biopsy development, as well as our latest scientific and clinical research findings during this conference.
Enhancing Precision Oncology with Advanced Liquid Biopsy Insights
Discover the transformative impact of liquid biopsy (LBx) in oncology, offering rapid, precise therapy selection and real-time monitoring of disease progression. Learn about Tempus AI's comprehensive LBx portfolio, designed to detect actionable tumor signals, monitor treatment outcomes, and derive new care insights. Explore the integration of advanced assays and AI-augmented platforms by Tempus, enhancing patient management and improving clinical outcomes.
Ezra Cohen, MDChief Medical Officer of Oncology, Tempus
Schedule a meeting with us
We'll be in touch shortly.